Almost 20% increased risk for antidepressant prescription among GLP-1 RA users: study

Possible impact of the medications on mood 'requires ongoing vigilance' Perth authors say.
HealthDay News

Patients taking GLP-1 receptor agonists face a greater risk for later being dispensed antidepressants, an Australian study shows.

Researchers from the University of Notre Dame in Perth found a 19% increased chance for antidepressant prescription among previously naive adults in those prescribed GLP-1 receptor agonists (RAs).